Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Myeloid, Acute 22Leukemia, Lymphocytic, Chronic, B-Cell 20Hodgkin Disease 19Lymphoma, Non-Hodgkin 16Lymphoma, Mantle-Cell 14Myelodysplastic Syndromes 13Myeloproliferative Disorders 12Lymphoma, Large B-Cell, Diffuse 12Multiple Myeloma 11Leukemia, Prolymphocytic 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Chronic-Phase 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Lymphoma 8Burkitt Lymphoma 8Myelodysplastic-Myeloproliferative Diseases 6Primary Myelofibrosis 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Biphenotypic, Acute 5Graft vs Host Disease 5Congenital Abnormalities 5Blast Crisis 5Anemia, Refractory, with Excess of Blasts 5Sezary Syndrome 4Mycosis Fungoides 4

Interventions

fludarabine phosphate 7pembrolizumab 6Mycophenolic Acid 6Peripheral Blood Stem Cell Transplantation 5Nivolumab 5Cyclosporine 5Cyclophosphamide 5Whole-Body Irradiation 4Radiotherapy 3Busulfan 3Antilymphocyte Serum 3temsirolimus 2fludarabine 2atezolizumab 2alectinib 2Tacrolimus 2Sunitinib 2Specimen Handling 2Paclitaxel 2Methotrexate 2Magnetic Resonance Spectroscopy 2Drug Therapy 2Dasatinib 2Alemtuzumab 2varlilumab 1valspodar 1utomilumab 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Cyclosporins × Lymphoid × Clear all
NCT00027820 2019-12-20

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
106 enrolled
Classical hematologyGenitourinaryLymphoidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡